p21 protein-activated kinase 1 is associated with severe regressive autism, and epilepsy.
Kristin D KernohanArran McBrideTaila HartleySamantha K Rojasnull nullDavid A DymentKym M BoycottSarah DyackPublished in: Clinical genetics (2019)
The p21-activated kinase (PAK) family of proteins function as key effectors of RHO family GTPases in mammalian cells to regulate many pathways including Ras/Raf/MEK/ERK and Wnt/β-catenin, amongst others. Here we report an individual with a novel autosomal dominant disorder characterized by severe regressive autism, intellectual disability, and epilepsy. Exome sequencing of the proband and her parents revealed a de novo variant in the PAK1 gene ([NM_001128620] c.362C>T/p.Pro121Leu). Studies in patient cells showed a clear effect on PAK1 protein function, including altered phosphorylation of targets (JNK and ERK), decreased abundance of β-catenin, and concomitant altered expression downstream of these key regulators. Our findings add PAK1 to the list of PAK proteins and kinases which when mutated cause rare genetic diseases.
Keyphrases
- intellectual disability
- cell proliferation
- autism spectrum disorder
- signaling pathway
- protein kinase
- induced apoptosis
- pi k akt
- copy number
- epithelial mesenchymal transition
- binding protein
- single cell
- cell cycle arrest
- early onset
- genome wide
- poor prognosis
- cell death
- stem cells
- photodynamic therapy
- protein protein
- tyrosine kinase
- case report
- dna methylation
- small molecule
- long non coding rna
- microbial community
- genome wide analysis